To be, or not to be
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cancer Research,Oncology
Reference53 articles.
1. Cancerp53, guardian of the genome.;Lane;Nature,1992
2. Surfing the p53 network.;Vogelstein;Nature,2000
3. Blinded by the light: the growing complexity of p53.;Vousden;Cell,2009
4. The first 30 years of p53: growing ever more complex.;Levine;Nat Rev Cancer,2009
5. p53, the cellular gatekeeper for growth and division.;Levine;Cell,1997
Cited by 48 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Regulation of the p53 Pathway;Encyclopedia of Cell Biology;2023
2. Synergistic Effect of Erastin Combined with Nutlin-3 on Vestibular Schwannoma Cells as p53 Modulates Erastin-Induced Ferroptosis Response;Journal of Oncology;2022-03-21
3. Probability Distributions of p53 Mutations and Their Corresponding Shannon Entropies in Different Cancer Cell Types;Trends in Biomathematics: Stability and Oscillations in Environmental, Social, and Biological Models;2022
4. Flubendazole, FDA-approved anthelmintic, elicits valid antitumor effects by targeting P53 and promoting ferroptosis in castration-resistant prostate cancer;Pharmacological Research;2021-02
5. HBXIP Regulates Gastric Cancer Glucose Metabolism and Malignancy Through PI3K/AKT and p53 Signaling;OncoTargets and Therapy;2020-04
HBXIP Regulates Gastric Cancer Glucose Metabolism and Malignancy Through PI3K/AKT and p53 Signaling
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3